Target Identification
Identify and validate the right therapeutic target
Finding the right therapeutic targets is the cornerstone of success.
Your goal is to bring life-changing therapies to market faster and more efficiently, and we are here to help you do that. Our Target Identification service is designed to turn complex data into actionable insights, so you can focus on what really matters: making a difference.
Navigating the complexities
Identifying and validating therapeutic targets can be a daunting task. We understand the obstacles researchers face: the lack of accessible, integrated data assets and the difficulty of consolidating insights from heterogeneous sources. Our goal is to tackle these challenges to accelerate drug discovery and reduce the risk of failure.
Bilogical Question
Data Exploration
Target Predictions
Target Assessment
Validation
Identifying and validating therapeutic targets
Discover actionable therapeutic targets in an ocean of biological data. Identify the targets that are relevant to your disease and can be effectively modulated by integrating and interpreting data from various sources.
Understanding target function
Uncover the target’s role in the disease by understanding its function in biological pathways and broader role in the disease progression. Generate insights from biological complexity and avoid pursuing targets that won’t ultimately deliver therapeutic success.
Ensuring safety and efficacy
Gain confidence in your targets by predicting druggability and assessing the potential for off-target effects. Remove a layer of uncertainty by ensuring that your targets will be both safe and effective before you move forward.
Selecting the right experimental models
Select the right preclinical model that accurately reflects patient biology to avoid misleading data and wasted resources. Ensure that your in vitro research translates into real-world outcomes by selecting the right models.
Reducing the time and cost of validation
Accelerate the experimental validation stage by starting with the most promising targets. Validate your in silico results in the lab faster and at a lower cost by tapping into our extensive network of partners.
Connect with our team to see how we can support your target identification efforts.
Innovations in action
Target discovery and prioritization
We leverage advanced Machine Learning to mine your multi-omics data and identify the most promising therapeutic targets. Our approach helps select the targets that are worth pursuing, saving you time and resources.
Target validation
Our rigorous validation process ensures that the targets you’re considering are not only relevant but also actionable. We reduce the risk of late-stage failures by screening the targets early on and providing you with the confidence you need to move forward.
Target deconvolution
Unraveling complex biological interactions helps you pinpoint the specific role of each target within its molecular and cellular environment. This deep understanding enables you to design more precise therapeutic interventions.
Indication expansion
We can help you unlock new therapeutic potentials for existing targets, expanding the scope of your research and opening up new treatment possibilities.
The edge you’ve been looking for
Increased probability of success
By focusing on the most promising targets, you increase your chances of successful drug development.
Accelerated drug discovery
Our streamlined processes and modern technologies reduce the time from target identification to validation.
Customized solutions
We tailor our approach to meet your specific research needs, ensuring that you get the most relevant and actionable insights.
Real-world impact
Case studies
What our
customers say?
- What started as a pilot project many years ago turned into a trusted broad collaboration between Ardigen and BI. Ardigen substantially contributed to several of our key projects, enabling us to significantly ramp up the scope of what we can achieve.
- Markus Bauer, PhD
- Global Computational Biology and Digital Sciences Therapeutic Area Oncology at Boehringer Ingelheim
- Ardigen provided several teams of high-calibre, multi-disciplined and proactive individuals to help Genomics England accelerate the transformation of population-scale bioinformatics pipelines. We are delighted with the collaboration and the outstanding results they have delivered. The bioinformatics and software engineering services they provided has helped us reduce project timelines and accelerate our development at a reasonable cost.
- Adrianto Wirawan, PhD
- Director of Bioinformatics Engineering at Genomics England
- Ardigen has been an exceptional partner to Sutro’s Informatics team, delivering top-notch software solutions tailored to our specific needs. The custom software developed by Ardigen has significantly improved the efficiency and accuracy of our workflows. Their commitment to quality and attention to detail are truly commendable. We highly appreciate their professionalism and look forward to continued collaboration.
- Hara Dilley
- Director, Informatics at Sutro Biopharma
- The feedback I have from the Clinical team is that your resources are doing an excellent job.
- Elian Winstanley
- Regional Manager Channel EMEA at Abbott Informatics
- Ardigen was instrumental in streamlining our processes with microbiome custom software development. Their deep expertise and unwavering commitment to the project led to significant and measurable improvements in the efficiency and quality of our research efforts. We highly recommend Ardigen for their outstanding and collaborative partnership in facilitating our research project. We are thrilled with the results and are exploring ways to continue our partnership.
- Martina Kluenemann, PhD
- Research Manager for Nutrition Immunology and Physiology, Evonik Operations GmbH
- Working with Ardigen has enabled us to apply precision bioinformatics and machine learning to our most pressing problems.
- Andy Greenstein
- Director, Translational Science at Corcept Therapeutics
- Ardigen has been a trusted partner to Alchemab for several years, helping us to accelerate our key software projects. Ardigen works seamlessly alongside our internal team, and we are always impressed by the quality of the work delivered.
- Jake Galson
- CTO at Alchemab Therapeutics
- Ardigen has been a great bioinformatics partner for Acrigen Biosciences. They were able to develop a custom bioinformatics workflow and wrap it in a web application, allowing easy access for our scientists.
- Michael Schelle
- Vice President Research and Operations at Acrigen Biosciences
- I’ve been really impressed with their expertise and communication skills. When we give them an analysis task, they go beyond what we’ve asked for and suggest and test new methods.
- Dr. Michael W. Rowe
- Director of Data Sciences at HeathTell
See also:
Contact
Ready to transform drug discovery?
Leave us a message and we will reach out to you within 24 hours, to tell you more about how we can empower your drug development journey.
Newsletter
Become an insider
Be the first to know about Ardigen’s latest news and get access to our publications, webinars and more!
